Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market

Medtronic’s Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage for expected sales growth in 2026.

Latest Ratings for MDT

DateFirmActionFromTo Feb 2022Credit SuisseMaintainsOutperform Feb 2022NeedhamMaintainsBuy Feb 2022Raymond JamesMaintainsOutperform

View More Analyst Ratings for MDT

View the Latest Analyst Ratings

read more